Episode

9AM HOUR: U.S.-Iran Effect on Markets, Chevron-Microsoft AI Power Deal, Greenspan Dies at 100 6/22/26

Podcast
Squawk on the Street
Published
Jun 22, 2026
Duration seconds
2495
Processing state
not_requested
Canonical source
https://www.cnbc.com
Audio
https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/772daf2b-4aa5-445b-9969-6ecd181231b1/episodes/e9d4bca5-07a4-42f1-93c6-ac423c9fd6de/audio/128/default.mp3?aid=rss_feed&awCollectionId=772daf2b-4aa5-445b-9969-6ecd181231b1&awEpisodeId=e9d4bca5-07a4-42f1-93c6-ac423c9fd6de&feed=GcylmXl7
JSON
/v1/public/podcasts/squawk-on-the-street-731896/episodes/9am-hour-u-s-iran-effect-on-markets-chevron-microsoft-ai-power-deal-greenspan-dies-at-100-6-22-26
Markdown
/podcast/squawk-on-the-street-731896/9am-hour-u-s-iran-effect-on-markets-chevron-microsoft-ai-power-deal-greenspan-dies-at-100-6-22-26.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/squawk-on-the-street-731896/episodes/9am-hour-u-s-iran-effect-on-markets-chevron-microsoft-ai-power-deal-greenspan-dies-at-100-6-22-26/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/squawk-on-the-street-731896/9am-hour-u-s-iran-effect-on-markets-chevron-microsoft-ai-power-deal-greenspan-dies-at-100-6-22-26.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Carl Quintanilla, David Faber and Sara Eisen led off the show with market reaction to positive comments by Vice President Vance about the U.S.-Iran negotiations. AI in the spotlight: Chevron announced it signed a 20-year agreement with Microsoft to provide power for the tech giant's massive West Texas data center project. The anchors remembered the influential former Fed chairman Alan Greenspan, who died Monday at the age of 100. Also in focus: President Trump's comments on Anthropic and national security, Microsoft CEO Satya Nadella's message for companies leading the AI boom, SpaceX shares on track for a three-day losing streak, AbbVie agrees to buy immunology drugmaker Apogee Therapeutics for $10.9 billion in cash. Squawk on the Street Disclaimer